Clinical Trials Sponsored by National institute of Siddha

Total 26617 results

National Cancer Institute (NCI)

Withdrawn

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cervical Cancer Early Endpoints and Determinants

Cervical Cancer | CIN | Neoplasia | Cervical Intraepithelial

United States
National Cancer Institute (NCI)

Completed

Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC

MDS | Immunodeficiency | GATA2

United States
Yale University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study

Smoking | Tobacco Abstinence

United States
National Cancer Institute (NCI)

Completed

Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers

Physical Activity | Body Composition | Puberty | Methylation

China
National Cancer Institute (NCI)

Terminated

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Sarcoma | Esophageal Cancer | Thymic Carcinoma | Lung Cancer | Malignant Pleural Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Recontacting Participants in the Observing Protein and Energy Nutrition (OPEN) Study: Re-OPEN

Diet | Diet Surveys

United States
National Cancer Institute (NCI)

Completed

Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident

Leukemia

Ukraine
National Cancer Institute (NCI)

Terminated

Von Hippel-Lindau Disease Genetic Epidemiology Study

Kidney Neoplasms | Von Hippel Lindau Disease

United States
National Cancer Institute (NCI)

Completed

A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)

Breast Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms

United States
National Cancer Institute (NCI)

Completed

AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer

Colon Cancer | Colonic Neoplasms | Colonic Cancer | Cancer of the Colon | Colon Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Amatuximab for High Mesothelin Cancers

Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Mesothelioma | Carcinoma, Pancreatic Ductal

United States
National Cancer Institute (NCI)

Terminated

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Breast Cancer | Lung Cancer | Renal Cancer | Adrenal Cancer

United States
National Cancer Institute (NCI)

Terminated

Relationship of Genetic Differences to the Development of Chromosome Abnormalities

Radiation Exposure

Russian Federation
National Cancer Institute (NCI)

Completed

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

Solid Tumors

United States
National Eye Institute (NEI)

Completed

Analyses of Existing Framingham Data

Eye Diseases

United States
National Cancer Institute (NCI)

Terminated

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Squamous Cell | Carcinoma, Non-Small Cell Lung | Carcinoma, Large Cell

United States
National Cancer Institute (NCI)

Completed

Feasibility Study of a Web-Based Automated Self-Administered 24-hour Dietary Recall (ASA 24) and a Physical Activity 24-hour Recall

Cancer

United States
National Cancer Institute (NCI)

Completed

ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Withdrawn

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Metastatic Thyroid Cancer
National Cancer Institute (NCI)

Withdrawn

Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.

Pediatric Leukemia | Pediatric Brain Neoplasms | Other Pediatric Cancers
National Cancer Institute (NCI)

Withdrawn

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Multiple Myeloma
National Eye Institute (NEI)

Completed

Evaluation and Treatment of People With Eye Diseases

Eye Diseases

United States
National Cancer Institute (NCI)

Completed

Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development

Cancer

United States
National Cancer Institute (NCI)

Terminated

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal Cancer

United States
National Cancer Institute (NCI)

Terminated

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Carcinoma, Non-Small-Cell Lung | Esophageal Neoplasms | Mesothelioma | Carcinoma, Small Cell

United States
National Cancer Institute (NCI)

Completed

Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies

Gene Transfer

United States
National Eye Institute (NEI)

Completed

Natural History and Genetic Studies of Usher Syndrome

Retinitis Pigmentosa | Usher Syndrome | Retinitis Pigmentosa Syndromic | Congenital Deafness | Retinitis Pigmentosa and Deafness

United States
National Cancer Institute (NCI)

Completed

AZD8055 for Adults With Recurrent Gliomas

Glioblastoma Multiforme | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Brainstem Glioma

United States
National Eye Institute (NEI)

Completed

Clinical and Genetic Studies in Families With Myopia and Related Diseases

Myopia

United States, China
National Cancer Institute (NCI)

Completed

An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...

Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

United States
National Cancer Institute (NCI)

Terminated

Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Eye Institute (NEI)

Terminated

Tissue Studies of Human Eye Diseases

Age-Related Macular Degeneration | Uveitis | Diabetic Retinopathy | Retinal Disease | Corneal Disease

United States
National Eye Institute (NEI)

Completed

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases

Glaucoma

United States, China
National Eye Institute (NEI)

Withdrawn

Ustekinumab for Active Sight-Threatening Uveitis

Uveitis
National Cancer Institute (NCI)

Terminated

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Esophageal Cancer | Thymoma | Lung Cancer | Thoracic Sarcomas | Mesolthelioma

United States
National Cancer Institute (NCI)

Terminated

A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes

PNET | Gliomas | Pineal Tumors | Ependymomas | PCNSL (Primary CNS Lymphoma)

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Terminated

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Melanoma | Metastatic Cancer

United States
National Cancer Institute (NCI)

Completed

Ketoconazole Plus Docetaxel to Treat Prostate Cancer

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Ixabepilone to Treat Cervical Cancer

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Carcinoma | Cervical Carcinoma, Non-SquamousType

United States
National Cancer Institute (NCI)

Completed

Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma

United States, Mexico, Bolivia, Peru, Venezuela
National Cancer Institute (NCI)

Completed

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Acute Myelogenous Leukemia | Refractory or Recurrent Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Neuroendocrine Tumors | Von Hippel-Lindau Syndrome | Hippel-Lindau Disease

United States
National Cancer Institute (NCI)

Terminated

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Multiple Myeloma | Smoldering Multiple Myeloma | Myeloma

United States
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Metastatic Renal Cell Cancer

United States
National Cancer Institute (NCI)

Withdrawn

GRN1005 for Brain Metastases From Breast or Lung Cancer

Breast Cancer | Breast Neoplasms | Lung Neoplasms | Lung Cancer
National Cancer Institute (NCI)

Terminated

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Malignant Melanoma

United States
National Cancer Institute (NCI)

Completed

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Histologically or Cytologically Confirmed Pancreatic Ca | Unresectable or Borderline Resectable Pancreatic Ca

United States
National Cancer Institute (NCI)

Completed

Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Prostatic Neoplasms

United States

Clinical Trials Sponsored by National institute of Siddha

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations